Table 3.

Trans fatty acid quartiles and risk of acute myocardial infarction, cardiovascular death and all-cause mortality

			Percentage by weight (wt%)						Concentration (mg/L)
Model	AMI		CV death		All-cause mortality		AMI		CV death		All-cause mortality
	HR	95 % CI	HR	95 % CI	HR	95 % CI	HR	95 % CI	HR	95 % CI	HR	95 % CI
Univariate
Q2	1.13	0.66, 1.93	1.69	0.74, 3.87	1.29	0.71, 2.36	1.10	0.66, 1.83	1.05	0.51, 2.15	0.96	0.55, 1.69
Q3	1.49	0.90, 2.45	1.92	0.86, 4.27	1.73	0.99, 3.04	1.05	0.63, 1.75	0.74	0.34, 1.60	0.95	0.54, 1.65
Q4	1.36	0.82, 2.25	2.39	1.11, 5.14	2.24	1.32, 3.82	1.25	0.77, 2.05	1.53	0.79, 2.96	1.84	1.13, 3.00
P-trend	0.15		0.03		0.03		0.42		0.28		0.01
P-interaction a	0.52		0.74		0.85		0.68		0.38		0.59
Age and sex adjusted
Q2	1.07	0.63, 1.84	1.36	0.59, 3.13	1.09	0.60, 2.01	1.11	0.67, 1.85	1.00	0.48, 2.04	0.94	0.54, 1.66
Q3	1.31	0.89, 2.18	1.23	0.54, 2.77	1.21	0.69, 2.15	1.02	0.61, 1.70	0.63	0.29, 1.38	0.85	0.49, 1.49
Q4	1.19	0.71, 2.00	1.44	0.65, 3.18	1.51	0.87, 2.62	1.25	0.76, 2.05	1.36	0.69, 2.65	1.73	1.06, 2.85
P-trend	0.41		0.45		0.10		0.46		0.49		0.02
P-interaction a	0.68		0.48		0.74		0.64		0.29		0.51
Multivariate adjustedb
Q2	1.10	0.64, 1.90	1.43	0.62, 3.31	1.18	0.64, 2.17	1.08	0.65, 1.80	1.00	0.48, 2.07	0.97	0.55, 1.71
Q3	1.43	0.86, 2.39	1.36	0.60, 3.09	1.36	0.76, 2.41	1.02	0.61, 1.72	0.62	0.28, 1.37	0.89	0.50, 1.56
Q4	1.14	0.67, 1.92	1.39	0.62, 3.11	1.53	0.87, 2.67	1.11	0.67, 1.84	1.11	0.56, 2.21	1.54	0.93, 2.55
P-trend	0.49		0.54		0.11		0.74		0.92		0.08
P-interaction a	0.64		0.72		0.80		0.77		0.41		0.74